Phillip G. Febbo - Feb 27, 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Feb 27, 2025
Transactions value $
-$765,110
Form type
4
Date filed
3/3/2025, 04:30 PM
Previous filing
Dec 6, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +30.6K +37.12% $0.00 113K Feb 27, 2025 Direct F1
transaction VCYT Common Stock Tax liability -$530K -15.7K -13.87% $33.84 97.3K Feb 27, 2025 Direct F2
transaction VCYT Common Stock Tax liability -$235K -6.75K -6.94% $34.76 90.6K Mar 2, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
F2 Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
F3 The reporting person is reporting the withholding of 1,688 and 5,066 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,323 and 9,976 Restricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.